Viewing Study NCT06590961


Ignite Creation Date: 2025-12-24 @ 12:08 PM
Ignite Modification Date: 2026-01-19 @ 6:54 AM
Study NCT ID: NCT06590961
Status: RECRUITING
Last Update Posted: 2025-11-19
First Post: 2024-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies
Sponsor: Ubix Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module